NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,401,432 | -0.1% | 53,028 | -1.0% | 0.10% | +4.2% |
| Q2 2023 | $5,406,052 | +6.2% | 53,573 | -3.2% | 0.10% | +1.1% |
| Q1 2023 | $5,089,808 | -1.7% | 55,324 | -3.1% | 0.09% | -6.9% |
| Q4 2022 | $5,177,027 | +16.7% | 57,066 | -2.3% | 0.10% | +5.2% |
| Q3 2022 | $4,438,000 | -9.2% | 58,385 | +1.0% | 0.10% | -6.8% |
| Q2 2022 | $4,888,000 | -5.1% | 57,816 | -1.5% | 0.10% | +12.0% |
| Q1 2022 | $5,150,000 | -5.3% | 58,686 | -5.6% | 0.09% | +3.4% |
| Q4 2021 | $5,437,000 | -1.4% | 62,159 | -7.8% | 0.09% | -9.2% |
| Q3 2021 | $5,514,000 | -21.1% | 67,423 | -12.0% | 0.10% | -27.4% |
| Q2 2021 | $6,993,000 | -10.6% | 76,644 | -16.3% | 0.14% | -15.1% |
| Q1 2021 | $7,824,000 | -11.2% | 91,528 | -1.9% | 0.16% | -13.6% |
| Q4 2020 | $8,809,000 | -1.1% | 93,288 | -8.9% | 0.18% | -12.4% |
| Q3 2020 | $8,908,000 | -1.8% | 102,443 | -1.4% | 0.21% | -6.7% |
| Q2 2020 | $9,075,000 | +4.4% | 103,902 | -1.5% | 0.22% | -10.7% |
| Q1 2020 | $8,694,000 | -13.8% | 105,445 | -1.1% | 0.25% | +7.2% |
| Q4 2019 | $10,091,000 | +5.8% | 106,569 | -2.9% | 0.24% | -1.7% |
| Q3 2019 | $9,538,000 | -1.9% | 109,754 | +3.1% | 0.24% | -6.3% |
| Q2 2019 | $9,722,000 | -3.5% | 106,472 | +1.6% | 0.26% | -5.9% |
| Q1 2019 | $10,077,000 | +8.0% | 104,809 | -3.6% | 0.27% | -5.2% |
| Q4 2018 | $9,330,000 | -0.8% | 108,730 | -0.4% | 0.29% | +8.3% |
| Q3 2018 | $9,402,000 | +11.4% | 109,127 | -2.4% | 0.26% | +3.1% |
| Q2 2018 | $8,442,000 | -15.9% | 111,762 | -10.0% | 0.26% | -17.4% |
| Q1 2018 | $10,037,000 | -1.3% | 124,152 | +2.5% | 0.31% | +2.6% |
| Q4 2017 | $10,170,000 | -3.4% | 121,136 | -1.3% | 0.30% | -6.8% |
| Q3 2017 | $10,532,000 | -0.1% | 122,679 | -2.9% | 0.32% | +0.3% |
| Q2 2017 | $10,541,000 | +8.2% | 126,280 | -3.8% | 0.32% | +8.4% |
| Q1 2017 | $9,745,000 | -6.4% | 131,212 | -8.2% | 0.30% | -11.6% |
| Q4 2016 | $10,407,000 | -18.4% | 142,876 | -11.5% | 0.34% | -22.9% |
| Q3 2016 | $12,750,000 | -6.4% | 161,468 | -2.2% | 0.44% | -8.8% |
| Q2 2016 | $13,624,000 | +2.9% | 165,124 | -9.7% | 0.48% | +2.4% |
| Q1 2016 | $13,244,000 | – | 182,820 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |